Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | AMGN | BMY | VRTX | REGN |
| Company | Gilead Sciences Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 89.07 | 288.18 | 58.16 | 454.24 | 744.87 |
| High | 89.94 | 290.21 | 58.38 | 455.43 | 757.56 |
| Low | 88.07 | 284.14 | 57.47 | 445.00 | 735.95 |
| Last | 89.64 | 289.96 | 58.21 | 450.74 | 753.78 |
| Change | +1.01 | +2.09 | +0.33 | -0.49 | +10.43 |
| % Change | +1.14% | +0.73% | +0.57% | -0.11% | +1.40% |
| Volume | 1,532,844 | 1,336,918 | 3,081,852 | 636,930 | 316,722 |
| 20-Day Average Volume | 7,399,830 | 2,806,995 | 12,173,468 | 1,301,151 | 839,645 |
| Previous Close | 88.63 | 287.87 | 57.88 | 451.23 | 743.35 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 90.89 | 307.38 | 55.92 | 479.22 | 825.89 |
| 20-Day Raw Stochastic | 29.25% | 25.72% | 69.42% | 6.51% | 9.68% |
| 20-Day Relative Strength | 53.73% | 35.87% | 60.74% | 40.79% | 20.62% |
| Weighted Alpha | +26.20 | +1.54 | +26.09 | +17.92 | -20.45 |
| Today's Opinion | 80% Buy | 40% Sell | 100% Buy | 8% Sell | 88% Sell |
| Previous Opinion | 80% Buy | 40% Sell | 100% Buy | 8% Sell | 88% Sell |
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | 8% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.48% since 11/14/24 | -2.30% since 11/14/24 | -0.44% since 11/14/24 | -7.02% since 11/14/24 | -3.38% since 11/14/24 |
| Low | 86.08 on 11/19/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 735.95 on 11/21/24 |
| High | 91.99 on 11/15/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 783.10 on 11/15/24 |
| 1-Month | |||||
| %Chg | +4.10% since 10/21/24 | -8.72% since 10/21/24 | +11.75% since 10/21/24 | -5.88% since 10/21/24 | -21.93% since 10/21/24 |
| Low | 85.60 on 10/22/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 735.95 on 11/21/24 |
| High | 98.90 on 11/11/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 972.74 on 10/22/24 |
| 3-Month | |||||
| %Chg | +19.57% since 08/21/24 | -12.16% since 08/21/24 | +20.24% since 08/21/24 | -7.43% since 08/21/24 | -36.21% since 08/21/24 |
| Low | 75.35 on 08/22/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 735.95 on 11/21/24 |
| High | 98.90 on 11/11/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | +33.50% since 05/21/24 | -8.18% since 05/21/24 | +37.79% since 05/21/24 | +1.81% since 05/21/24 | -23.93% since 05/21/24 |
| Low | 62.07 on 05/31/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 735.95 on 11/21/24 |
| High | 98.90 on 11/11/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 110,456,552 | 154,739,632 | 117,390,888 | 116,204,808 | 81,686,728 |
| Shares Outstanding, K | 1,246,266 | 537,533 | 2,028,177 | 257,529 | 109,890 |
| Annual Sales | 27,116,000,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | 5,665,000,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 7,545,000,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 3,720,700,000 |
| Last Quarter Net Income | 1,253,000,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,340,600,000 |
| 60-Month Beta | 0.17 | 0.60 | 0.44 | 0.39 | 0.15 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.02 on 11/06/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 12.46 on 10/31/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 10/31/24 | 11/04/24 | 10/31/24 |
| Most Recent Dividend | 0.770 on 09/13/24 | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | N/A |
| Next Ex-Dividends Date | 12/13/24 | 11/18/24 | 10/04/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 19.81 | 14.57 | 49.77 | 0.00 | 18.62 |